1. Home
  2. GWW vs REGN Comparison

GWW vs REGN Comparison

Compare GWW & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo W.W. Grainger Inc.

GWW

W.W. Grainger Inc.

N/A

Current Price

$1,261.54

Market Cap

60.2B

Sector

Industrials

ML Signal

N/A

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

N/A

Current Price

$777.20

Market Cap

68.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GWW
REGN
Founded
1927
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.2B
68.8B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
GWW
REGN
Price
$1,261.54
$777.20
Analyst Decision
Hold
Buy
Analyst Count
7
25
Target Price
$1,118.14
$830.16
AVG Volume (30 Days)
210.1K
529.5K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
0.79%
0.55%
EPS Growth
N/A
8.19
EPS
23.66
18.95
Revenue
N/A
$5,872,227,000.00
Revenue This Year
$6.73
$12.45
Revenue Next Year
$6.90
$10.13
P/E Ratio
$53.66
$40.85
Revenue Growth
N/A
20.82
52 Week Low
$906.52
$541.00
52 Week High
$1,419.91
$859.34

Technical Indicators

Market Signals
Indicator
GWW
REGN
Relative Strength Index (RSI) 40.01 44.16
Support Level $1,260.22 $732.04
Resistance Level $1,286.56 $782.44
Average True Range (ATR) 24.39 19.05
MACD -2.75 -9.90
Stochastic Oscillator 13.67 5.05

Price Performance

Historical Comparison
GWW
REGN

About GWW W.W. Grainger Inc.

Founded in 1927, W.W. Grainger originally distributed various motors via a mail-order catalog. Over the course of the 20th century, the firm expanded into new industrial product categories and launched its first digital catalog in 1995. Today, the company organizes itself into two segments focused on different customer bases. Its larger segment, high-touch solutions, offers a vast array of maintenance, repair, and operations, or MRO, supplies and bespoke inventory management services to larger businesses. Its smaller segment, endless assortment, operates two online platforms, Zoro and MonotaRO, that offer comprehensive catalogs of MRO supplies to smaller businesses. Grainger has operations throughout the world but primarily generates sales within the US.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: